News

Podcast

Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care

Author(s):

Urology Times staff

In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in recognition of Bladder Cancer Awareness Month.

In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in recognition of Bladder Cancer Awareness Month this May. During the discussion he touches on his own clinical practice, recent advances in the field, data on bladder cancer presented at the recent AUA meeting, including his own study, "Mental health illness in patients with non-muscle invasive bladder cancer. Does BCG play a role?", and more.

Kamat is a professor of urologic oncology at University of Texas MD Anderson Cancer Center in Houston.

Don’t forget to subscribe to Speaking of Urology® on Spotify, Apple Podcasts, or anywhere that podcasts are available.

Related Videos
Interpreting ART toxicity and tolerability for bladder cancer, with Vedang Murthy, MD
Trinity Bivalacqua, MD, PhD, and Mark Tyson, MD, MPH, experts on bladder cancer
Trinity Bivalacqua, MD, PhD, and Mark Tyson, MD, MPH, experts on bladder cancer
Trinity Bivalacqua, MD, PhD, and Mark Tyson, MD, MPH, experts on bladder cancer
Related Content
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
October 11th 2024

Upper tract urothelial carcinoma: An in-depth review for urologists

Jesse Persily, MD Sameer Thakker, MD Katie S. Murray, DO, MS
"On-going innovation will continue to drive UTUC management forward, and with it will come on-going challenges of how to best study a relatively rare disease," write the authors.
Key updates from the AUA/ASRM male infertility guideline amendment
September 23rd 2024

Key updates from the AUA/ASRM male infertility guideline amendment

Urology Times staff
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
Andrea Necchi, MD, on promising SunRISe-4 data of TAR-200 in MIBC
October 9th 2024

Andrea Necchi, MD, on promising SunRISe-4 data of TAR-200 in MIBC

Hannah Clarke
"Overall, TAR-200 is being tested with the aim of changing the therapeutic paradigm of patients with an early bladder cancer diagnosis, including non–muscle-invasive disease and muscle-invasive disease," says Andrea Necchi, MD.
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
July 24th 2024

Speaking of Urology: Dr. Winter on the use of vaginal estrogen

Urology Times staff
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
Phase 3 trial progresses of padeliporfin VTP therapy in upper tract urothelial carcinoma
September 30th 2024

Phase 3 trial progresses of padeliporfin VTP therapy in upper tract urothelial carcinoma

Hannah Clarke
The phase 3 ENLIGHTED trial has reached the 50% patient enrollment threshold.
Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
September 27th 2024

3D bioprinting technology facilitates development of an in vitro biomimetic bladder model

Kate Gessner, MD, PhD Philip Abbosh, MD, PhD
"This exciting and innovative technology has a wide range of possible applications, including tissue engineering, drug development, and precision medicine," write Kate Gessner, MD, PhD, and Philip Abbosh, MD, PhD.
© 2024 MJH Life Sciences

All rights reserved.